PETALING JAYA: UMediC Group Bhd
is expected to post stronger sequential earnings moving forward to be driven by increased capacity at its manufacturing segments and improved marketing and distribution segment, says Phillip Capital Research.
However, the research house has cut the group’s financial year 2025 (FY25) to FY27 earnings forecasts by 8% to 16% to account for slower-than-expected sales from the distribution segment coupled with lower margin expectation.
